๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Living Donor Liver Transplantation in Japanese Registry

โœ Scribed by H. Egawa; Y. Ueda; T. Ichida; S. Teramukai; Y. Nakanuma; S. Onishi; H. Tsubouchi


Book ID
114805856
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
335 KB
Volume
11
Category
Article
ISSN
1600-6135

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Risk factors for recurrence of primary s
โœ Evangelos Cholongitas; Vibhakorn Shusang; George V. Papatheodoridis; Laura Marel ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 94 KB ๐Ÿ‘ 2 views

Liver transplantation (LT) is the only therapeutic option for end-stage primary sclerosing cholangitis (PSC), but PSC can recur (rPSC) in some patients after LT. The aim of our study was to evaluate the risk factors associated with rPSC. Between 1989 and 2004, 69 patients receiving transplantation f

Risk factors for recurrence of primary s
โœ Jacob Alexander; James D. Lord; Matthew M. Yeh; Carlos Cuevas; Ramasamy Bakthava ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 123 KB ๐Ÿ‘ 2 views

Orthotopic liver transplantation (OLT) is the only effective treatment for end-stage liver disease due to primary sclerosing cholangitis (PSC). Recurrence of PSC has recently emerged as a leading cause of allograft failure in the long term. There is limited data on risk factors for recurrence of PSC

Reply: The urgent need for evaluating re
โœ Edward Biobele Alabraba; Darius Mirza; James Neuberger ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 38 KB

We thank Tamura et al. 1 for their thought-provoking letter indicating that there are indeed still a lot of questions to be answered about the recurrence of primary sclerosing cholangitis (PSC). They suggested that a comparison of risk factors and rates of recurrence in living and deceased donor gra